Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 29, 2017
Pharmacy Choice - Pharmaceutical News - Rep. Bilirakis Applauds Progress on Drug Prices, Public Health Bills - May 29, 2017

Pharmacy News Article

 5/19/17 - Rep. Bilirakis Applauds Progress on Drug Prices, Public Health Bills

WASHINGTON, May 18 Rep. Gus Bilirakis, R-Fla., issued the following news release:

Today, U.S. Rep. Gus Bilirakis (FL-12) applauded progress made on legislation he championed to lower the price of prescription medication, and reauthorize research programs for congenital heart disease and sickle cell disease.

During the markup, Bilirakis spoke on the importance of incentivizing generic drug production to tackle the issue of high drug prices. He worked closely on a provision in the FDA Reauthorization Act which would accelerate the generic drug approval process and encourage generic drug makers to enter markets where there is no competition.

"Too often, bad actors in the marketplace take advantage of monopolies, skyrocketing the price of lifesaving medication simply because there is little to no competition," Bilirakis said.

The Congressman also discussed legislation he introduced, the Congenital Heart Futures Reauthorization Act, which continues research on the treatment and prevention of congenital heart disease (CHD). "For the sake of the estimated 40,000 babies who will be born in the next year with CHD, there's more work to be done to better understand this diagnosis," Bilirakis noted.

The bills were approved by the Energy and Commerce Subcommittee on Health, and will next be considered by the entire Energy and Commerce Committee before reaching the House floor.

Please click here (https://energycommerce.house.gov/hearings-and-votes/markups/subcommittee-vote-hr-1222-hr-2410-and-hr-fda-reauthorization-act-2017) for more information on the bills: the FDA Reauthorization Act (H.R. 2430), the Congenital Heart Futures Reauthorization Act (H.R. 1222), and the Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act (H.R. 2410).



Targeted News Service

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
May 30: The American Geriatric Society Beers Criteria: Implications for Pharmacy Practice
May 31: Medication Safety & Drug Safety Alerts
Jun 01: Adult Immunizations: A Guide for Pharmacists, Techs & NPs
Jun 05: Headache Disorders: Focus on Migraines & Tension Headaches
Jun 06: Men's Health
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415